Unexplained Visual Loss After Silicone Oil Removal: A 7-Year Retrospective Study.
Retinal detachment
Silicone oil
Unexplained visual loss
Vitrectomy
Journal
Ophthalmology and therapy
ISSN: 2193-8245
Titre abrégé: Ophthalmol Ther
Pays: England
ID NLM: 101634502
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
26
11
2019
pubmed:
14
5
2020
medline:
14
5
2020
entrez:
14
5
2020
Statut:
ppublish
Résumé
Unexplained visual loss after removal of silicone oil from the eye has been described. The purpose of this study is to determine the incidence of unexplained loss of visual acuity after SO removal and to provide possible explanations for this phenomenon. This retrospective study included patients that underwent vitreoretinal surgery, at Centro Hospitalar São João, between January of 2012 and October of 2018. Inclusion criterion was vitreoretinal surgery in which the chosen endotamponade was SO, followed by removal of SO and exchange with balanced salt solution (BSS) or air. After SO removal, patients with documented loss of best corrected visual acuity (BCVA) on two or more Snellen lines were analyzed and patients in which the cause of the visual loss was identified, namely OHT (intraocular pressure > 21 mmHg), retinal re-detachment, glaucoma, retinal proliferative membrane formation, or corneal decompensation, were excluded. All patients with unexplained visual loss underwent spectral domain optical coherence tomography (SD-OCT) to exclude causes of visual reduction such as cystoid macular edema, epiretinal membrane, or ellipsoid/interdigitation zone disruption. A p value less than 0.05 was considered statistically significant. A total of 46 eyes underwent SO tamponade and SO removal during the study period. In 34.8% of the cases (n = 16) there was visual acuity loss in at least two Snellen lines. Of 46 eyes, 23.9% (n = 11) showed vision loss due to known secondary causes. Unexplained loss of visual acuity after SO removal occurred in 10.9% of cases. OHT during silicone endotamponade (p = 0.046) and silicone emulsification (p = 0.001) were identified as factors associated with unexplained visual loss after SO removal. Unexplained loss of visual acuity after SO removal occurred in 10.9% of cases. OHT during silicone endotamponade and SO emulsification were identified as important factors in the ethology of this phenomenon.
Identifiants
pubmed: 32399859
doi: 10.1007/s40123-020-00259-5
pii: 10.1007/s40123-020-00259-5
pmc: PMC7406612
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1-13Références
Biomaterials. 2000 Apr;21(7):649-65
pubmed: 10711963
Retina. 1991;11(2):259-65
pubmed: 1925093
Retina. 2005 Jun;25(4):515-7
pubmed: 15933601
Int J Retina Vitreous. 2017 Jul 24;3:26
pubmed: 28748109
Biomed Res Int. 2015;2015:713828
pubmed: 26557694
Expert Rev Ophthalmol. 2008 Apr;3(2):211-218
pubmed: 19343097
Ophthalmology. 1988 May;95(5):614-8
pubmed: 3174023
Retina. 2016 Feb;36(2):342-50
pubmed: 26308530
Biomed Res Int. 2014;2014:502143
pubmed: 25013785
Ophthalmologe. 1996 Apr;93(2):121-5
pubmed: 8652975
Retina. 2008 Jul-Aug;28(7):996-1001
pubmed: 18698303
Arch Ophthalmol. 1986 Jul;104(7):1057-62
pubmed: 3729775
Retina. 2010 Feb;30(2):300-4
pubmed: 19920769
Retina. 2005 Sep;25(6):808-9; author reply 809
pubmed: 16141884
Ophthalmology. 1993 Nov;100(11):1629-35
pubmed: 8233387
Arch Ophthalmol. 1987 Apr;105(4):546-50
pubmed: 3566611
Ophthalmologica. 2001 Jul-Aug;215(4):276-83
pubmed: 11399935
Coll Antropol. 2013 Apr;37 Suppl 1:227-35
pubmed: 23837249
Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):35-9
pubmed: 22562478
Biomed Res Int. 2014;2014:574825
pubmed: 25114909
Graefes Arch Clin Exp Ophthalmol. 1986;224(1):34-7
pubmed: 3943733
Retina. 1992;12(3 Suppl):S28-32
pubmed: 1455079
Brain Res Bull. 2007 Sep 14;74(1-3):130-3
pubmed: 17683798
Br J Ophthalmol. 2001 Nov;85(11):1324-7
pubmed: 11673299
Retina. 2017 Dec;37(12):2334-2340
pubmed: 28098737
Ophthalmologe. 1996 Apr;93(2):130-8
pubmed: 8652977
Graefes Arch Clin Exp Ophthalmol. 1991;229(1):88-94
pubmed: 2004732
Am J Ophthalmol. 1993 Nov 15;116(5):557-64
pubmed: 8238214
Arch Ophthalmol. 1999 Feb;117(2):189-95
pubmed: 10037563
Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1465-1471
pubmed: 27278374
Br J Ophthalmol. 2010 Apr;94(4):509-12
pubmed: 19955199
Retina. 2013 Apr;33(4):791-7
pubmed: 23117281
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1873-83
pubmed: 17389523
Invest Ophthalmol Vis Sci. 1990 Oct;31(10):2059-69
pubmed: 2211003
Ophthalmic Surg Lasers Imaging Retina. 2014 Jan-Feb;45(1):71-3
pubmed: 24392916
BMC Ophthalmol. 2006 May 31;6:21
pubmed: 16737520
Graefes Arch Clin Exp Ophthalmol. 2004 Jul;242(7):617-20
pubmed: 15029505
Br J Ophthalmol. 2005 Jul;89(7):799-802
pubmed: 15965152
PLoS One. 2017 Mar 1;12(3):e0172895
pubmed: 28248989
Retina. 2004 Dec;24(6):871-7
pubmed: 15579983
Optometry. 2006 Sep;77(9):446-9
pubmed: 16939886
Ophthalmology. 1994 Dec;101(12):1908-12
pubmed: 7997327
Acta Ophthalmol. 2012 Dec;90(8):733-7
pubmed: 21914150
Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1585-93
pubmed: 19685070
Klin Monbl Augenheilkd. 2010 Mar;227(3):181-4
pubmed: 20234980
Arch Ophthalmol. 1992 Oct;110(10):1468-71
pubmed: 1417548
Eye (Lond). 2015 Nov;29(11):1477-82
pubmed: 26248526
Clin Ophthalmol. 2008 Dec;2(4):955-9
pubmed: 19668452
Graefes Arch Clin Exp Ophthalmol. 2002 Oct;240(10):829-34
pubmed: 12397431
Graefes Arch Clin Exp Ophthalmol. 1990;228(1):19-23
pubmed: 2311940
Graefes Arch Clin Exp Ophthalmol. 2006 Feb;244(2):248-52
pubmed: 16047183
Arch Biochem Biophys. 2007 Feb 1;458(1):48-56
pubmed: 16712775
Ann Ophthalmol. 1972 Apr;4(4):273-87
pubmed: 4260540
Invest Ophthalmol Vis Sci. 1989 Feb;30(2):220-4
pubmed: 2914752
Br J Ophthalmol. 2005 Dec;89(12):1668
pubmed: 16299160
Int Ophthalmol. 1999;23(1):17-24
pubmed: 11008894
Doc Ophthalmol. 1993;83(1):79-82
pubmed: 8334923
Graefes Arch Clin Exp Ophthalmol. 2005 Apr;243(4):345-58
pubmed: 15864624
J Cataract Refract Surg. 2002 Feb;28(2):376-8
pubmed: 11821226
Br J Ophthalmol. 2007 Feb;91(2):253-7
pubmed: 17005543
Klin Oczna. 2011;113(4-6):146-8
pubmed: 21913444
Invest Ophthalmol Vis Sci. 1991 Nov;32(12):3007-20
pubmed: 1938278
Retina. 2001;21(2):107-14
pubmed: 11321135
Ophthalmology. 1992 Oct;99(10):1520-6
pubmed: 1454317
Can J Ophthalmol. 1986 Dec;21(7):271-5
pubmed: 3801975
Ophthalmology. 1988 Jul;95(7):870-6
pubmed: 3174036
Arch Ophthalmol. 1987 Sep;105(9):1269-72
pubmed: 3632446
Graefes Arch Clin Exp Ophthalmol. 1987;225(6):452-6
pubmed: 3678857
Retina. 1993;13(4):285-9
pubmed: 8115727
Br J Ophthalmol. 2004 Nov;88(11):1439-42
pubmed: 15489490
Ophthalmology. 1998 Sep;105(9):1587-97
pubmed: 9754162
Ger J Ophthalmol. 1994 Mar;3(2):65-7
pubmed: 8193573
Eye (Lond). 1991;5 ( Pt 3):333-7
pubmed: 1955056
Invest Ophthalmol Vis Sci. 2000 Jan;41(1):256-61
pubmed: 10634628
Br J Ophthalmol. 1989 Dec;73(12):991-5
pubmed: 2611197
Am J Ophthalmol. 1991 Apr 15;111(4):434-8
pubmed: 2012145
J Cataract Refract Surg. 2001 Mar;27(3):437-44
pubmed: 11255058
Arch Ophthalmol. 1983 Sep;101(9):1399-401
pubmed: 6615306
Graefes Arch Clin Exp Ophthalmol. 2004 Aug;242(8):699-703
pubmed: 15309556